ENTITY
Viva Biotech Holdings

Viva Biotech Holdings (1873 HK)

73
Analysis
Health CareChina
Viva Biotech Holdings operates as a drug discovery platform. The Company provides target protein expression, structure researching, hit screening, drug candidate determination, and other services. Viva Biotech Holdings serves customers worldwide.
more
Refresh
22 Apr 2019 15:33

Viva Biotech IPO Preview: Show Me the Money

Viva Biotech Shanghai Ltd (1577881D HK) is a leading global contract research organisation (CRO). Viva has started pre-marketing for a Hong Kong...

Logo
594 Views
Share
13 Apr 2019 12:37

ECM Weekly (13 April 2019) - So-Young, Japan Post Trio, Shenwan Hongyuan, Changliao, Uber

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
28 Mar 2019 15:48

Viva Biotech (维亚生物) IPO: Warning Signs from 2018 Numbers (Part 2)

Viva Biotechnology, a China-based drug discovery company, is seeking to raise USD 200m to list on the Hong Kong Stock Exchange. It has recently...

Logo
794 Views
Share
bullishSea
09 Mar 2019 13:19

ECM Weekly (9 March 2019) - Lyft, Shenwan Hongyuan, RHB Bank, Sea Ltd, Xinyi Solar, China Gas

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
12 Jan 2019 14:49

ECM Weekly (12 January 2019) - Futu, China East Education, China Kepei Education, Viva Biotech

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
x